Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one?

被引：1
|
作者：
Del Prato, Stefano [1 ]
机构：
[1] Univ Pisa, Dept Clin & Expt Med, Sect Diabet & Metab Dis, I-56124 Pisa, Italy
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2014年 / 2卷 / 11期
关键词：
D O I：
10.1016/S2213-8587(14)70185-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：856 / 858
页数：4
相关论文
共 50 条
  • [21] Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature
    Balena, R.
    Hensley, I. E.
    Miller, S.
    Barnett, A. H.
    DIABETES OBESITY & METABOLISM, 2013, 15 (06): : 485 - 502
  • [22] Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes
    Ivona Risovic
    Mirjana Sumarac Dumanovic
    Mirjana Bojic
    Danijel Djekic
    BMC Endocrine Disorders, 23
  • [23] Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes
    Risovic, Ivona
    Dumanovic, Mirjana Sumarac
    Bojic, Mirjana
    Djekic, Danijel
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [24] ADDING RAPID-ACTING INSULIN OR GLP-1 RECEPTOR AGONIST TO BASAL INSULIN: OUTCOMES IN A COMMUNITY SETTING
    Dalal, Mehul R.
    Xie, Lin
    Baser, Onur
    DiGenio, Andres
    ENDOCRINE PRACTICE, 2015, 21 (01) : 68 - 76
  • [25] The rationale for combining GLP-1 receptor agonists with basal insulin
    Cohen, Neale D.
    Audehm, Ralph
    Pretorius, Elaine
    Kaye, Joey
    Chapman, Leon H.
    Colagiuri, Stephen
    MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (04) : 246 - 249
  • [26] Weight Reduction with a Combination of the prandial GLP-1-Receptor Agonist Lixisenatide with Basal Insulin
    Simonsohn, Michael
    Fleischmann, Holger
    Mihaljevic, Roman
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 550 - 551
  • [27] Titratable fixed-ratio combination of basal insulin plus a glucagon-like peptide-1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes
    Gomez-Peralta, Fernando
    Al-Ozairi, Ebaa
    Jude, Edward B.
    Li, Xiaoying
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1445 - 1452
  • [28] Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
    Valentine, Virginia
    Goldman, Jennifer
    Shubrook, Jay H.
    DIABETES THERAPY, 2017, 8 (04) : 739 - 752
  • [29] ADDING RAPID-ACTING INSULIN OR GLP-1 RECEPTOR AGONIST TO BASAL INSULIN: PENNY WISE AND POUND FOOLISH?
    Grajower, Martin M.
    ENDOCRINE PRACTICE, 2015, 21 (01) : 88 - 90
  • [30] Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
    Virginia Valentine
    Jennifer Goldman
    Jay H. Shubrook
    Diabetes Therapy, 2017, 8 : 739 - 752
12345